Literature DB >> 20399348

The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy.

Ljuba Bacharova1, Harvey Estes, Lia Bang, Ian Rowlandson, Giuseppe Schillaci, Paolo Verdecchia, Peter W Macfarlane.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20399348     DOI： 10.1016/j.jelectrocard.2010.03.003

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN： 0022-0736            Impact factor:   1.438


× No keyword cloud information.
  10 in total

1.  Second statement of the working group on electrocardiographic diagnosis of left ventricular hypertrophy.

Authors:  Ljuba Bacharova; E Harvey Estes; Lia E Bang; Joseph A Hill; Peter W Macfarlane; Ian Rowlandson; Giuseppe Schillaci
Journal:  J Electrocardiol       Date:  2011-07-14       Impact factor: 1.438

2.  Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Jonathan Chrispin; Aditya Jain; Elsayed Z Soliman; Eliseo Guallar; Alvaro Alonso; Susan R Heckbert; David A Bluemke; João A C Lima; Saman Nazarian
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

Review 3.  Chlorthalidone: mechanisms of action and effect on cardiovascular events.

Authors:  George C Roush; Venkata Buddharaju; Michael E Ernst; Theodore R Holford
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

Review 4.  Hypertrophic reprogramming of the left ventricle: translation to the ECG.

Authors:  Joseph A Hill
Journal:  J Electrocardiol       Date:  2012-09-19       Impact factor: 1.438

5.  Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  Michael E Ernst; Barry R Davis; Elsayed Z Soliman; Ronald J Prineas; Peter M Okin; Alokananda Ghosh; William C Cushman; Paula T Einhorn; Suzanne Oparil; Richard H Grimm
Journal:  J Am Soc Hypertens       Date:  2016-11-09

6.  The Romhilt-Estes left ventricular hypertrophy score and its components predict all-cause mortality in the general population.

Authors:  E Harvey Estes; Zhu-Ming Zhang; Yabing Li; Larisa G Tereschenko; Elsayed Z Soliman
Journal:  Am Heart J       Date:  2015-04-13       Impact factor: 4.749

7.  Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial.

Authors:  Michael E Ernst; James D Neaton; Richard H Grimm; Gary Collins; William Thomas; Elsayed Z Soliman; Ronald J Prineas
Journal:  Hypertension       Date:  2011-10-24       Impact factor: 10.190

8.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.

Authors:  Elsayed Z Soliman; Robert P Byington; J Thomas Bigger; Gregory Evans; Peter M Okin; David C Goff; Haiying Chen
Journal:  Hypertension       Date:  2015-10-12       Impact factor: 10.190

9.  Improvement of electrocardiographic diagnostic accuracy of left ventricular hypertrophy using a Machine Learning approach.

Authors:  Fernando De la Garza-Salazar; Maria Elena Romero-Ibarguengoitia; Elias Abraham Rodriguez-Diaz; Jose Ramón Azpiri-Lopez; Arnulfo González-Cantu
Journal:  PLoS One       Date:  2020-05-13       Impact factor: 3.240

Review 10.  The role of ECG in the diagnosis of left ventricular hypertrophy.

Authors:  Ljuba Bacharova; Douglas Schocken; Edward H Estes; David Strauss
Journal:  Curr Cardiol Rev       Date:  2014-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.